How many institutions own DMRA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DMRA shares is N/A, representing N/A of the company's common stock.

Who are the major shareholders selling Damora Therapeutics, Inc. stock?

N/A, in the last quarter, reduced its stake in DMRA by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the DMRA shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned DMRA shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying DMRA stock?

As per its latest 13F filing, BLACKROCK, INC. increased its stake in DMRA by 2,857.94% in the last quarter. The institutional holder raised its holding to 222.44 thousand shares having worth more than $5.76M. MORGAN STANLEY also added 29.18% more shares of DMRA to its portfolio, raising its holding to 96.78 thousand shares of worth $2.51M. VANGUARD FIDUCIARY TRUST CO also increased its DMRA shares holding by 100% which brought its holding to 96.66 thousand shares worth $2.50M.

DMRA's major insiders: who are they?

The insider with the most stakes in DMRA is Winslow Garrett , General Counsel at the company. Additionally, DMRA stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell DMRA stock?

Company executives, directors, and other insiders own N/A percent of Damora Therapeutics, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which DMRA insiders have sold stock, totaling 245 shares. Insiders that have sold shares include WINSLOW GARRETT.

Which insider recently purchased DMRA stock?

There have been 0 transaction(s) during the past 6-months in which Damora Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of DMRA does insiders own?

Around 2.29K Damora Therapeutics, Inc. shares are held by insiders, which represents about N/A of DMRA stock.

Who is the insider with the largest stake?

DMRA General Counsel, Winslow Garrett holds the largest portfolio of the company's shares. DMRA shares owned by Winslow total nearly 2.29 thousand.

Which institution holds the most shares in DMRA?

BLACKROCK, INC. is the largest institutional owner in DMRA which holds 222.44 thousand shares worth $5.76M or 0.65% of the total DMRA shares outstanding followed by MORGAN STANLEY with ownership of 96.78 thousand shares representing 0.28% of the DMRA ownership. VANGUARD FIDUCIARY TRUST CO is the third largest stakeholder with 96.66 thousand shares or 0.28% of the ownership worth more than $2.50M.

Is Damora Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DMRA is concerned, it is a stock which is optionable.

Is there a short position on DMRA's shares?

Number of DMRA shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding DMRA shares are there?

As of today, N/A shares of DMRA are outstanding.

Is there many float in DMRA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DMRA has N/A shares in float.

DMRA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DMRA is N/A.

Damora Therapeutics (DMRA) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

N/A

Short % of Float

N/A

Short % of Shares Outstanding

Institutional Ownership

About N/A of shares are held by financial institutions. BLACKROCK, INC. is the top corporate investor, holding 222.44K shares valued at $5.76M. A 0.65% stake in Damora Therapeutics, Inc. is owned by the company. MORGAN STANLEY owns 96.78K shares valued at $2.51M, which translates its holding of 0.28% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	BLACKROCK, INC.	0.65%	222.44K	5.76M	214.92K	+2,857.94%
Mar 31, 2026	MORGAN STANLEY	0.28%	96.78K	2.51M	21.86K	+29.18%
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.28%	96.66K	2.5M	96.66K	+100.00%
Mar 31, 2026	GOLDMAN SACHS GROUP INC	0.26%	88.34K	2.29M	88.34K	+100.00%
Mar 31, 2026	HUDSON BAY CAPITAL MANAGEMENT LP	0.22%	76.34K	1.98M	76.34K	+100.00%
Mar 31, 2026	BREVAN HOWARD CAPITAL MANAGEMENT LP	0.16%	55.23K	1.43M	55.23K	+100.00%
Mar 31, 2026	NORTHERN TRUST CORP	0.11%	38.88K	1.01M	38.88K	+100.00%
Mar 31, 2026	JANUS HENDERSON GROUP PLC	6.89%	2.36M	61.44M	2.36M	+135,765.21%
Mar 31, 2026	BARCLAYS PLC	0.06%	22.03K	570.68K	22.03K	+100.00%
Mar 31, 2026	CATALYST FUNDS MANAGEMENT PTY LTD	0.05%	17.29K	447.89K	17.29K	+100.00%
Mar 31, 2026	CORMORANT ASSET MANAGEMENT, LP	4.45%	1.53M	39.5M	1.53M	+100.00%
Mar 31, 2026	BALYASNY ASSET MANAGEMENT L.P.	4.22%	1.45M	37.5M	1.45M	+100.00%
Mar 31, 2026	VESTAL POINT CAPITAL, LP	1.75%	600K	15.54M	600K	+100.00%
Mar 31, 2026	BLACKSTONE INC.	1.47%	503.52K	13.04M	503.52K	+100.00%
Mar 31, 2026	MILLENNIUM MANAGEMENT LLC	1.38%	471.65K	12.22M	471.65K	+100.00%
Mar 31, 2026	AFFINITY ASSET ADVISORS, LLC	1.31%	450K	11.66M	450K	+100.00%
Mar 31, 2026	IKARIAN CAPITAL, LLC	0.98%	335.71K	8.69M	50K	+17.50%
Mar 31, 2026	QUBE RESEARCH & TECHNOLOGIES LTD	0.82%	282.44K	7.32M	282.44K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.7%	241.13K	6.25M	229.55K	+1,983.52%
Mar 31, 2026	MARSHALL WACE, LLP	0.5%	169.82K	4.4M	169.82K	+100.00%
Mar 31, 2026	UBS GROUP AG	0.47%	160.42K	4.15M	154.03K	+2,410.80%
Mar 31, 2026	AMERIPRISE FINANCIAL INC	0.34%	117.68K	3.05M	117.68K	+100.00%
Mar 31, 2026	BOOTHBAY FUND MANAGEMENT, LLC	0.32%	110.44K	2.86M	14.64K	+15.29%
Mar 31, 2026	HRT FINANCIAL LP	0.21%	72.11K	1.87M	72.11K	+100.00%
Mar 31, 2026	LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	0.07%	24.46K	633.41K	24.46K	+100.00%
Mar 31, 2026	SQUAREPOINT OPS LLC	0.07%	23.46K	607.56K	23.46K	+100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0.05%	15.65K	405.26K	14.42K	+1,174.19%
Mar 31, 2026	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.04%	12.5K	323.75K	12.5K	+100.00%
Mar 31, 2026	STATE STREET CORP	0.54%	183.92K	4.76M	183.92K	+100.00%
Mar 31, 2026		0.3%	101.25K	2.62M	101.25K	+100.00%
Mar 31, 2026	FMR LLC	26.37%	9.05M	234.28M	8.81M	+3,686.65%
Mar 31, 2026	FAIRMOUNT FUNDS MANAGEMENT LLC	25.4%	8.71M	225.67M	8.71M	+100.00%
Mar 31, 2026	AVORO CAPITAL ADVISORS LLC	11.03%	3.78M	97.98M	3.78M	+100.00%
Mar 31, 2026	VR ADVISER, LLC	10.51%	3.6M	93.33M	3.6M	+100.00%
Mar 31, 2026	FCPM III SERVICES B.V.	7.12%	2.44M	63.22M	2.44M	+100.00%
Mar 31, 2026	RA CAPITAL MANAGEMENT, L.P.	7%	2.4M	62.14M	2.4M	+100.00%
Mar 31, 2026	JANE STREET GROUP, LLC	0.03%	11.42K	295.78K	11.42K	+100.00%
Mar 31, 2026	CITIGROUP INC	0.03%	11.1K	287.36K	9.97K	+884.47%
Mar 31, 2026	SCHONFELD STRATEGIC ADVISORS LLC	0.03%	10.82K	280.34K	10.82K	+100.00%
Mar 31, 2026	VIKING GLOBAL INVESTORS LP	6.74%	2.31M	59.86M	2.31M	+100.00%
Mar 31, 2026	BELLEVUE GROUP AG	6.7%	2.3M	59.52M	2.3M	+100.00%
Mar 31, 2026	COMMODORE CAPITAL LP	5.65%	1.94M	50.22M	1.94M	+100.00%
Mar 31, 2026	ADAR1 CAPITAL MANAGEMENT, LLC	0.81%	279K	7.23M	279K	+100.00%
Mar 31, 2026	NANTAHALA CAPITAL MANAGEMENT, LLC	0.81%	278K	7.2M	278K	+100.00%
Mar 31, 2026	AH CAPITAL MANAGEMENT, L.L.C.	3.6%	1.24M	32.02M	1.24M	+100.00%
Mar 31, 2026	PERCEPTIVE ADVISORS LLC	3.57%	1.22M	31.68M	1.22M	+100.00%
Mar 31, 2026	POINT72 ASSET MANAGEMENT, L.P.	3.48%	1.19M	30.92M	1.08M	+995.15%
Mar 31, 2026	WELLINGTON MANAGEMENT GROUP LLP	3.08%	1.06M	27.4M	1.06M	+100.00%
Mar 31, 2026	SIREN, L.L.C.	2.62%	900K	23.31M	900K	+100.00%
Mar 31, 2026	BRAIDWELL LP	2.61%	894.85K	23.18M	894.85K	+100.00%

Insiders

Among the DMRA insiders holding of N/A of the stake in company, WINSLOW GARRETT, General Counsel, holds the largest shares of 2.29K. , , is the second largest DMRA insider with ownership of - shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
WINSLOW GARRETT	General Counsel	2.29K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jul 06, 2026	WINSLOW GARRETT	SALE	29.98	245	7.35K	2.29K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE00

SALES2451

NET SHARES-2451

SHARES HELD2.29K1

% NET SHARES-110.7%0%

DMRA Stock Ownership Breakdown